Fingerprint
Dive into the research topics of 'Survival advantage from imatinib compared with the combination interferon-α plus cytarabine in chronic-phase chronic myelogenous leukemia: Historical comparison between two phase 3 trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically